Compound ID | 1925
Class: Beta-lactam (aminopenicillin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and some Enterobacteriaceae, but vulnerable to penicillinases produced by staphylococci and E. coli |
| Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA). Oral (bacampicillin, pivampicillin) and parenteral application. Fixed combination with sulbactam available. |
| Institute where first reported: | Sandoz |
| Year first mentioned: | 1953 |
| Highest development stage: | Approved by FDA in 1971 |
| Development status: | Approved, off-patent |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6249 |
| Guide to Pharmacology: | ampicillin |
| Citations: |
|